David Krige
Chief Development Officer (CDO) @Accession Therapeutics Limited
Oxford, GB
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Sep 2025 — Present
Chief Development Officer (CDO) @Accession Therapeutics Limited
View department →
Oxford, GB
EDUCATION
1988 — 1989
UCL
MSc, Applied Molecular Biology and Biotechnology; distinction
1985 — 1988
Queen Mary University of London
BSc, Genetics
1990 — 1994
Royal Free Hospital, University of London
PhD, Biochemistry
SKILLS
Cell BiologyGenomicsDrug DiscoveryCell Based AssaysMolecular BiologyOncologyBiochemistry
ABOUT DAVID KRIGE
drug discovery, with focus on oncology and inflammationSpecialties: drug discovery, cell biology, cell-based assays, molecular biology, genomics, biochemistry, assay development
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.